APA (7th ed.) Citation

Schneider, S. A., D'Amora, P., Evans, S. S., Kent, P., Stockwell, T., Bakaya, V. S., . . . Nagourney, R. A. (2026). Functional Precision Oncology in Fibrolamellar Carcinoma: Ex Vivo Identification of Therapeutic Vulnerabilities. Cancers, 18(11), 1744. https://doi.org/10.3390/cancers18111744

Chicago Style (17th ed.) Citation

Schneider, Sabina A., et al. "Functional Precision Oncology in Fibrolamellar Carcinoma: Ex Vivo Identification of Therapeutic Vulnerabilities." Cancers 18, no. 11 (2026): 1744. https://doi.org/10.3390/cancers18111744.

MLA (9th ed.) Citation

Schneider, Sabina A., et al. "Functional Precision Oncology in Fibrolamellar Carcinoma: Ex Vivo Identification of Therapeutic Vulnerabilities." Cancers, vol. 18, no. 11, 2026, p. 1744, https://doi.org/10.3390/cancers18111744.